nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—NR1I2—metabolic syndrome X	0.889	1	CbGaD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.00739	0.12	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.0058	0.0945	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—NR1H3—metabolic syndrome X	0.00531	0.0865	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00425	0.0692	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR1H3—metabolic syndrome X	0.00419	0.0683	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—NR1I3—metabolic syndrome X	0.00388	0.0633	CbGpPWpGaD
Rifaximin—Rifampicin—NR1I2—metabolic syndrome X	0.00314	1	CrCbGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR1I3—metabolic syndrome X	0.00307	0.05	CbGpPWpGaD
Rifaximin—Upset stomach—Metformin—metabolic syndrome X	0.00252	0.0541	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00223	0.0363	CbGpPWpGaD
Rifaximin—Rhinorrhoea—Metformin—metabolic syndrome X	0.00204	0.0437	CcSEcCtD
Rifaximin—Contusion—Metformin—metabolic syndrome X	0.0019	0.0406	CcSEcCtD
Rifaximin—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.00179	0.0291	CbGpPWpGaD
Rifaximin—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.00158	0.0257	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00155	0.0252	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—NR3C1—metabolic syndrome X	0.00151	0.0246	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARA—metabolic syndrome X	0.00141	0.023	CbGpPWpGaD
Rifaximin—Ear pain—Metformin—metabolic syndrome X	0.00141	0.0301	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00128	0.0208	CbGpPWpGaD
Rifaximin—Hypoglycaemia—Metformin—metabolic syndrome X	0.00123	0.0263	CcSEcCtD
Rifaximin—Pain in extremity—Metformin—metabolic syndrome X	0.0012	0.0257	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.00119	0.0194	CbGpPWpGaD
Rifaximin—Migraine—Metformin—metabolic syndrome X	0.00118	0.0253	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptors—PPARG—metabolic syndrome X	0.00117	0.0191	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.00112	0.0182	CbGpPWpGaD
Rifaximin—Dehydration—Metformin—metabolic syndrome X	0.00112	0.0239	CcSEcCtD
Rifaximin—Abdominal pain upper—Metformin—metabolic syndrome X	0.0011	0.0235	CcSEcCtD
Rifaximin—Nasopharyngitis—Metformin—metabolic syndrome X	0.00107	0.023	CcSEcCtD
Rifaximin—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.00107	0.0174	CbGpPWpGaD
Rifaximin—Abdominal distension—Metformin—metabolic syndrome X	0.00104	0.0224	CcSEcCtD
Rifaximin—Sweating increased—Metformin—metabolic syndrome X	0.00101	0.0216	CcSEcCtD
Rifaximin—Abdominal discomfort—Metformin—metabolic syndrome X	0.000995	0.0213	CcSEcCtD
Rifaximin—Neutropenia—Metformin—metabolic syndrome X	0.00097	0.0208	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000964	0.0207	CcSEcCtD
Rifaximin—Infestation—Metformin—metabolic syndrome X	0.000925	0.0198	CcSEcCtD
Rifaximin—Infestation NOS—Metformin—metabolic syndrome X	0.000925	0.0198	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.000924	0.0151	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.000855	0.0139	CbGpPWpGaD
Rifaximin—Rhinitis—Metformin—metabolic syndrome X	0.000833	0.0178	CcSEcCtD
Rifaximin—Hypoaesthesia—Metformin—metabolic syndrome X	0.000826	0.0177	CcSEcCtD
Rifaximin—Oedema peripheral—Metformin—metabolic syndrome X	0.000818	0.0175	CcSEcCtD
Rifaximin—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.000792	0.0129	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.000782	0.0127	CbGpPWpGaD
Rifaximin—Flushing—Metformin—metabolic syndrome X	0.000771	0.0165	CcSEcCtD
Rifaximin—Angiopathy—Metformin—metabolic syndrome X	0.000754	0.0161	CcSEcCtD
Rifaximin—Mediastinal disorder—Metformin—metabolic syndrome X	0.000749	0.016	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.000724	0.0118	CbGpPWpGaD
Rifaximin—Malnutrition—Metformin—metabolic syndrome X	0.000723	0.0155	CcSEcCtD
Rifaximin—Flatulence—Metformin—metabolic syndrome X	0.000713	0.0153	CcSEcCtD
Rifaximin—Muscle spasms—Metformin—metabolic syndrome X	0.000695	0.0149	CcSEcCtD
Rifaximin—Tremor—Metformin—metabolic syndrome X	0.000677	0.0145	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000671	0.0109	CbGpPWpGaD
Rifaximin—Ill-defined disorder—Metformin—metabolic syndrome X	0.000671	0.0144	CcSEcCtD
Rifaximin—Malaise—Metformin—metabolic syndrome X	0.000652	0.014	CcSEcCtD
Rifaximin—Syncope—Metformin—metabolic syndrome X	0.000648	0.0139	CcSEcCtD
Rifaximin—Loss of consciousness—Metformin—metabolic syndrome X	0.000636	0.0136	CcSEcCtD
Rifaximin—Myalgia—Metformin—metabolic syndrome X	0.000616	0.0132	CcSEcCtD
Rifaximin—Chest pain—Metformin—metabolic syndrome X	0.000616	0.0132	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000611	0.0131	CcSEcCtD
Rifaximin—Discomfort—Metformin—metabolic syndrome X	0.000608	0.013	CcSEcCtD
Rifaximin—Infection—Metformin—metabolic syndrome X	0.000586	0.0126	CcSEcCtD
Rifaximin—Shock—Metformin—metabolic syndrome X	0.000581	0.0124	CcSEcCtD
Rifaximin—Nervous system disorder—Metformin—metabolic syndrome X	0.000579	0.0124	CcSEcCtD
Rifaximin—Skin disorder—Metformin—metabolic syndrome X	0.000573	0.0123	CcSEcCtD
Rifaximin—Hyperhidrosis—Metformin—metabolic syndrome X	0.00057	0.0122	CcSEcCtD
Rifaximin—Anorexia—Metformin—metabolic syndrome X	0.000563	0.012	CcSEcCtD
Rifaximin—Hypotension—Metformin—metabolic syndrome X	0.000551	0.0118	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000538	0.0115	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00053	0.00864	CbGpPWpGaD
Rifaximin—Dyspnoea—Metformin—metabolic syndrome X	0.000526	0.0113	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000515	0.0084	CbGpPWpGaD
Rifaximin—Decreased appetite—Metformin—metabolic syndrome X	0.000513	0.011	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000509	0.0109	CcSEcCtD
Rifaximin—Fatigue—Metformin—metabolic syndrome X	0.000509	0.0109	CcSEcCtD
Rifaximin—Constipation—Metformin—metabolic syndrome X	0.000505	0.0108	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000491	0.008	CbGpPWpGaD
Rifaximin—Feeling abnormal—Metformin—metabolic syndrome X	0.000486	0.0104	CcSEcCtD
Rifaximin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000483	0.0103	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—EDC4—metabolic syndrome X	0.000478	0.00779	CbGpPWpGaD
Rifaximin—Urticaria—Metformin—metabolic syndrome X	0.000469	0.01	CcSEcCtD
Rifaximin—Abdominal pain—Metformin—metabolic syndrome X	0.000467	0.00999	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000449	0.00732	CbGpPWpGaD
Rifaximin—Asthenia—Metformin—metabolic syndrome X	0.000423	0.00907	CcSEcCtD
Rifaximin—Pruritus—Metformin—metabolic syndrome X	0.000418	0.00894	CcSEcCtD
Rifaximin—Diarrhoea—Metformin—metabolic syndrome X	0.000404	0.00865	CcSEcCtD
Rifaximin—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.000398	0.00649	CbGpPWpGaD
Rifaximin—Dizziness—Metformin—metabolic syndrome X	0.00039	0.00836	CcSEcCtD
Rifaximin—Vomiting—Metformin—metabolic syndrome X	0.000375	0.00803	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000374	0.0061	CbGpPWpGaD
Rifaximin—Rash—Metformin—metabolic syndrome X	0.000372	0.00797	CcSEcCtD
Rifaximin—Dermatitis—Metformin—metabolic syndrome X	0.000372	0.00796	CcSEcCtD
Rifaximin—Headache—Metformin—metabolic syndrome X	0.00037	0.00792	CcSEcCtD
Rifaximin—Nausea—Metformin—metabolic syndrome X	0.000351	0.00751	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NR1H3—metabolic syndrome X	0.000349	0.00568	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000258	0.0042	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR1I3—metabolic syndrome X	0.000255	0.00416	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.000206	0.00336	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.000199	0.00324	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000196	0.00319	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000193	0.00315	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000179	0.00291	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000175	0.00285	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.00016	0.0026	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000148	0.00241	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.000144	0.00234	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SIRT1—metabolic syndrome X	0.000112	0.00182	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR3C1—metabolic syndrome X	9.92e-05	0.00162	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARA—metabolic syndrome X	9.29e-05	0.00151	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARG—metabolic syndrome X	7.68e-05	0.00125	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SERPINE1—metabolic syndrome X	6.92e-05	0.00113	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	6.83e-05	0.00111	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FMO3—metabolic syndrome X	3.4e-05	0.000554	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AKT1—metabolic syndrome X	3.04e-05	0.000495	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	3.03e-05	0.000494	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	3.03e-05	0.000494	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	2.85e-05	0.000464	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FABP4—metabolic syndrome X	2.42e-05	0.000395	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	2.3e-05	0.000374	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—G6PD—metabolic syndrome X	2.05e-05	0.000333	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	2e-05	0.000326	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.95e-05	0.000318	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.95e-05	0.000318	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.89e-05	0.000308	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.87e-05	0.000305	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.74e-05	0.000284	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.56e-05	0.000254	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.55e-05	0.000253	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.55e-05	0.000253	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.54e-05	0.000251	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.5e-05	0.000244	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.43e-05	0.000234	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.39e-05	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.35e-05	0.000221	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.35e-05	0.000221	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.21e-05	0.000197	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.21e-05	0.000197	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.17e-05	0.00019	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.17e-05	0.00019	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOB—metabolic syndrome X	9.91e-06	0.000162	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	9.64e-06	0.000157	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPL—metabolic syndrome X	9.46e-06	0.000154	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CD36—metabolic syndrome X	8.99e-06	0.000147	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARA—metabolic syndrome X	8.36e-06	0.000136	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AGT—metabolic syndrome X	8.1e-06	0.000132	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOE—metabolic syndrome X	7.93e-06	0.000129	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA1—metabolic syndrome X	7.84e-06	0.000128	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARG—metabolic syndrome X	6.91e-06	0.000113	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—INS—metabolic syndrome X	6.78e-06	0.00011	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—metabolic syndrome X	6.21e-06	0.000101	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NOS3—metabolic syndrome X	5.94e-06	9.69e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	5.44e-06	8.86e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.73e-06	4.45e-05	CbGpPWpGaD
